Intellectual Property India Publishes Patent Application for 'Solid Forms, Salts And Polymorphs Of Anti-Fibrotic Compounds' Filed by Certa Therapeutics Pty Ltd.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517073000 A) filed by Certa Therapeutics Pty Ltd., Melbourne, Australia, on July 31, for 'solid forms, salts and polymorphs of anti-fibrotic compounds.'

Inventor(s) include Kelly, Darren; Lewis, Gareth; and Mitchell, Lorna.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to solid forms and salts, crystalline and otherwise, of (E)- 2-[[3-(3-methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid and pharmaceutical compositions comprising same. The use of such solid forms, salts, and pharmaceutical compositions, for treating, preventing, or ameliorating diseases or conditions associated with fibrosis, inflammation and/or proliferation are disclosed."

The patent application was internationally filed on Dec. 20, 2023, under International application No.PCT/AU2023/051332.

Disclaimer: Curated by HT Syndication.